AtriCure
ATRC
109 hedge funds and large institutions have $552M invested in AtriCure in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 37 reducing their positions, and 18 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 37
1.24% more ownership
Funds ownership: 86.49% → 87.73% (+1.2%)
4% less funds holding
Funds holding: 114 → 109 (-5)
17% less capital invested
Capital invested by funds: $664M → $552M (-$113M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$14.6M |
| 2 |
BlackRock
New York
|
+$9.79M |
| 3 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$4.15M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.75M |
| 5 |
HEC
Hudson Executive Capital
New York
|
+$2.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$6.96M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$5.06M |
| 3 |
BG
Bollard Group
Boston,
Massachusetts
|
-$4.47M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$4.03M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.68M |
ATRC Hedge Fund Activity: Q4 2017 in Review
109 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2017, worth a combined $552M — down 17% from $664M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of ATRC and 13 opened new positions — a net loss of 5 holders — while 37 trimmed existing stakes and 42 added.
The largest buyer was Wellington Management Group, adding an estimated $14.6M. The largest seller was Millennium Management, cutting an estimated $6.96M.
- 109 institutional investors held AtriCure (ATRC) as of Q4 2017, down from 114 in Q3 2017.
- Funds reported $552M of AtriCure stock for Q4 2017, down 17% quarter-over-quarter.
- 13 funds opened new AtriCure positions in Q4 2017 and 18 closed out, a net change of -5 holders.
- The largest AtriCure buyer in Q4 2017 was Wellington Management Group, an estimated $14.6M added.
- The largest AtriCure seller in Q4 2017 was Millennium Management, an estimated $6.96M sold.
Based on aggregated 13F filings for Q4 2017.